Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy
- 1 October 2008
- journal article
- Published by Elsevier in Brachytherapy
- Vol. 7 (4) , 305-309
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Five-year results: the initial clinical trial of Mammosite balloon brachytherapy for partial breast irradiation in early-stage breast cancerThe American Journal of Surgery, 2007
- Complications in Breast SurgerySurgical Clinics of North America, 2007
- Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical studyThe American Journal of Surgery, 2006
- Accelerated Partial Breast Irradiation Using the MammoSite Device: Early Technical Experience and Short-Term Clinical Follow-UpThe American Surgeon™, 2006
- Clinical experience with the MammoSite® radiation therapy system for brachytherapy of breast cancer: Results from an international phase II trialRadiotherapy and Oncology, 2006
- Persistent seroma after intraoperative placement of MammoSite for accelerated partial breast irradiation: Incidence, pathologic anatomy, and contributing factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Evidence-Based Risk Factors for Seroma Formation in Breast SurgeryJapanese Journal of Clinical Oncology, 2006
- Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trialThe American Journal of Surgery, 2005
- Early Experience With Balloon Brachytherapy for Breast CancerArchives of Surgery, 2004
- Conservative Surgery and Radiation Therapy for Early Breast CancerArchives of Surgery, 1989